Rosenblum Silverman Sutton S F Inc. CA reduced its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Get Rating) by 2.6% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 25,778 shares of the medical research company’s stock after selling 694 shares during the period. Thermo Fisher Scientific makes up 5.2% of Rosenblum Silverman Sutton S F Inc. CA’s investment portfolio, making the stock its 3rd biggest position. Rosenblum Silverman Sutton S F Inc. CA’s holdings in Thermo Fisher Scientific were worth $14,196,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently made changes to their positions in the stock. Richard W. Paul & Associates LLC bought a new stake in Thermo Fisher Scientific in the fourth quarter worth $34,000. Live Oak Investment Partners purchased a new position in shares of Thermo Fisher Scientific in the fourth quarter valued at about $36,000. Grey Fox Wealth Advisors LLC purchased a new position in shares of Thermo Fisher Scientific in the fourth quarter valued at about $43,000. Baystate Wealth Management LLC increased its position in shares of Thermo Fisher Scientific by 36.7% in the fourth quarter. Baystate Wealth Management LLC now owns 82 shares of the medical research company’s stock valued at $45,000 after acquiring an additional 22 shares during the period. Finally, Affiance Financial LLC purchased a new position in shares of Thermo Fisher Scientific in the fourth quarter valued at about $48,000. 85.92% of the stock is owned by institutional investors.
Insider Transactions at Thermo Fisher Scientific
In related news, CEO Marc N. Casper sold 1,600 shares of the stock in a transaction that occurred on Tuesday, May 9th. The shares were sold at an average price of $534.82, for a total transaction of $855,712.00. Following the transaction, the chief executive officer now owns 141,330 shares in the company, valued at $75,586,110.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, CEO Marc N. Casper sold 10,000 shares of the stock in a transaction that occurred on Friday, May 5th. The shares were sold at an average price of $545.22, for a total transaction of $5,452,200.00. Following the transaction, the chief executive officer now owns 141,330 shares in the company, valued at $77,055,942.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Marc N. Casper sold 1,600 shares of the stock in a transaction that occurred on Tuesday, May 9th. The shares were sold at an average price of $534.82, for a total transaction of $855,712.00. Following the transaction, the chief executive officer now owns 141,330 shares in the company, valued at approximately $75,586,110.60. The disclosure for this sale can be found here. Insiders own 0.32% of the company’s stock.
Wall Street Analysts Forecast Growth
Thermo Fisher Scientific Trading Down 1.1 %
NYSE:TMO opened at $520.27 on Thursday. Thermo Fisher Scientific Inc. has a one year low of $475.77 and a one year high of $611.06. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.27 and a quick ratio of 0.92. The company’s 50-day simple moving average is $541.45 and its 200 day simple moving average is $553.92. The firm has a market capitalization of $200.68 billion, a P/E ratio of 33.92, a PEG ratio of 2.61 and a beta of 0.79.
Thermo Fisher Scientific (NYSE:TMO – Get Rating) last issued its earnings results on Wednesday, April 26th. The medical research company reported $5.03 earnings per share (EPS) for the quarter, hitting the consensus estimate of $5.03. The firm had revenue of $10.71 billion for the quarter, compared to the consensus estimate of $10.67 billion. Thermo Fisher Scientific had a net margin of 13.75% and a return on equity of 19.16%. The business’s revenue was down 9.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $7.25 earnings per share. As a group, analysts forecast that Thermo Fisher Scientific Inc. will post 23.69 EPS for the current fiscal year.
Thermo Fisher Scientific Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, July 14th. Stockholders of record on Thursday, June 15th will be paid a $0.35 dividend. The ex-dividend date of this dividend is Wednesday, June 14th. This represents a $1.40 annualized dividend and a dividend yield of 0.27%. Thermo Fisher Scientific’s dividend payout ratio is presently 9.13%.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Featured Stories
- Get a free copy of the StockNews.com research report on Thermo Fisher Scientific (TMO)
- Game-Changing News For AMD And Its Shareholders
- How to Read Stock Charts for Beginners
- Can Chegg’s AI Pivot Save It From Disruption?
- Best Investment Strategy in 2023: Determine the Right One for You
- Enovix: A Rising Power in the Lithium-Ion Industry
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO – Get Rating).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
